Anaplastic thyroid cancer with life-threatening symptoms in an older female - a case report
DOI:
https://doi.org/10.12775/JEHS.2023.41.01.009Keywords
anaplastic thyroid carcinoma, undifferentiated thyroid carcinoma, thyroid cancer, dyspnea, dysphagia, thyroid massAbstract
Introduction: Anaplastic thyroid cancer, also called undifferentiated, is an uncommon and highly aggressive thyroid neoplasm that usually occurs in patients above 60 years of age (mean 65 years). Incidence is about 1-2 cases per million persons a year. [11] It accounts for 1-2% of thyroid cancer cases and probably develops from previously differentiated thyroid neoplasms. [1] Mutations of TP53 gene are most common and exist in 17-80% of patients. Other frequently mutated genes are RAS, BRAF and β-catenin. [3] The metastatic spread tends to occur through hematogenous and lymphatic pathways. The neoplasm presents as a rapidly enlarging neck mass that can cause compression on the neck structures giving symptoms such as dysphagia and dyspnea. Patients with established diagnosis of anaplastic thyroid cancer have very poor prognosis. Mean survival time of patients after confirmed diagnosis is 3 to 6 months and 5-year survival rate is estimated to be 5-14%. [2]
Aim: The aim of this study is to portray the clinical presentation, course and complications of a patient suffering from anaplastic thyroid cancer. This case report includes performed procedures and implemented treatment.
Description of the case: We present a case of an 87-year-old female that was admitted to the hospital with a large thyroid mass, symptoms of dysphagia, dyspnea and significant weight loss. Clinical picture was suspicious of anaplastic thyroid cancer. Further workup included laboratory testing, imaging and FNA biopsy. Surgical procedure of tracheostomy was conducted due to life-threatening dyspnea with consecutive patient’s monitoring in Intensive Care Unit. After achieving clinically stable state the patient was transferred to Clinical Department of Radiotherapy where palliative radiotherapy was initiated.
References
Chintakuntlawar AV, Ryder M, Bible KC. Anaplastic Thyroid Cancer and Primary Thyroid Lymphoma. Elsevier; 2021: p. 246-254.e3
Chintakuntlawar AV, Foote RL, Kasperbauer JL, Bible KC. Diagnosis and Management of Anaplastic Thyroid Cancer. Endocrinol Metab Clin North Am. 2019 Mar;48(1):269-284. doi: 10.1016/j.ecl.2018.10.010. PMID: 30717908.
Reddi H, Kumar A, Kulstad R. Anaplastic thyroid cancer – an overview of genetic variations and treatment modalities. Advances in Genomics and Genetics. 2015;5:43-52 https://doi.org/10.2147/AGG.S53448
Maniakas A, Zafereo M, Cabanillas ME. Anaplastic Thyroid Cancer: New Horizons and Challenges. Endocrinol Metab Clin North Am. 2022 Jun;51(2):391-401. doi: 10.1016/j.ecl.2021.11.020. Epub 2022 May 4. PMID: 35662448.
Smith N, Nucera C. Personalized therapy in patients with anaplastic thyroid cancer: targeting genetic and epigenetic alterations. J Clin Endocrinol Metab. 2015 Jan;100(1):35-42. doi: 10.1210/jc.2014-2803. PMID: 25347569; PMCID: PMC4283016.
Julie A. Sosa, Rossella Elisei, Barbara Jarzab, Jai Balkissoon, et al. Randomized Safety and Efficacy Study of Fosbretabulin with Paclitaxel/Carboplatin Against Anaplastic Thyroid Carcinoma. Thyroid®.Feb 2014.232-240.http://doi.org/10.1089/thy.2013.0078
Bible KC, Kebebew E, Brierley J, Brito JP, et al.. 2021 American Thyroid Association Guidelines for Management of Patients with Anaplastic Thyroid Cancer. Thyroid. 2021 Mar;31(3):337-386. doi: 10.1089/thy.2020.0944. Erratum in: Thyroid. 2021 Oct;31(10):1606-1607. PMID: 33728999; PMCID: PMC8349723.
Xu J, Liao Z, Li JJ, Wu XF, Zhuang SM. The Role of Tracheostomy in Anaplastic Thyroid Carcinoma. World J Oncol. 2015 Feb;6(1):262-264. doi: 10.14740/wjon899w. Epub 2015 Feb 14. PMID: 29147413; PMCID: PMC5649943.
Neff, R.L., et al., Anaplastic thyroid cancer. Endocrinol Metab Clin North Am, 2008. 37(2): p. 525-38, xi.
Maniakas A, Dadu R, Busaidy NL, et al. Evaluation of Overall Survival in Patients With Anaplastic Thyroid Carcinoma, 2000-2019. JAMA Oncol. 2020;6(9):1397–1404. doi:10.1001/jamaoncol.2020.3362
Davies L, Welch HG. Increasing incidence of thyroid cancer in the United States, 1973-2002. JAMA. 2006 May 10;295(18):2164-7. doi: 10.1001/jama.295.18.2164. PMID: 16684987.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Wojciech Pawęska, Hanna Dominik, Barbara Dominik
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 230
Number of citations: 0